WORCESTER, Mass., Aug. 14, 2007 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that the results of a Generex Oral-lyn(tm) study have been published in Diabetes Technology & Therapeutics.
